Teva: Is $1.1 Billion Asset Sale Much Ado About Nothing?

Teva new CEO Kare Schultz

Teva (TEVA) has had some exciting news to present over the past week. It hired 30-year industry veteran Kare Schultz as its full-time CEO. He will be charged with rightsizing the business while simultaneously paring debt. To that end, the company completed the $1.1 billion sale of its Paragard intrauterine copper contraceptive to CooperSurgical:

READ FULL ARTICLE HERE

Recent Deals

Interested in advertising your deals? Contact Edwin Warfield.